Physician profile

Christopher E Cenac

Orthopaedic Surgery of the Spine · Houma, LA

NPI 1366414732

$33,068.99

in general payments reported to CMS, 2019-2025

45 companies · $8,044 in 2025

The $8,044 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).

See the full distribution for Orthopaedic Surgery of the Spine

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$7,568.00
Travel and Lodging$1,603.96
Food and Beverage$1,471.72

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Centinel Spine, LLC $12,500.00 2019
Precision Spine, INC. $11,414.39 2021-2025
Zavation Medical Products, LLC $3,670.88 2024-2025
Life Spine, INC. $1,772.25 2022-2023 Centric-S, Cervical Plage, Prolift Pivot
Abbott Laboratories $469.32 2024-2025 Eterna, Proclaim
Corelink, LLC $306.44 2019-2021
Amgen INC. $248.32 2019-2022
Providence Medical Technology, INC. $223.62 2021-2024
Alphatec Spine, INC $189.05 2022
Si-Bone, INC. $188.15 2019-2023
Medtronic USA, INC. $168.79 2019
Seaspine Orthopedics Corporation $140.29 2021
Ferring Pharmaceuticals INC. $129.67 2019-2022
Nuvasive, INC. $122.51 2020
Orthofix Medical, INC. $109.85 2023 Mariner Mis Tlif Retractor, Meridian
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Globus Medical, INC. $107.01 2021
Nexxt Spine LLC $98.64 2022-2024 Connexx Mis System, Struxxure Mcs System
Radius Health, INC. $94.80 2019-2023
Neo Spine USA, INC. $89.97 2021
Collegium Pharmaceutical, INC. $82.40 2019
Depuy Synthes Sales INC. $82.36 2020-2021
Stryker Corporation $72.31 2025 Aequalis Perform Reversed
Arbor Pharmaceuticals, INC. $70.27 2019-2021
Spineology INC. $68.84 2023 Optimesh Expandable Interbody Fusion System
Pacira Pharmaceuticals Incorporated $66.61 2019-2024 Exparel, Iovera, Zilretta
Medtronic, INC. $48.68 2021-2024 Invos
Allergan, INC. $44.74 2019
Lifenet Health $43.90 2022
Forte Bio-Pharma LLC $42.59 2019-2021
Horizon Therapeutics Plc $41.76 2019
Integrity Implants INC. Dba Accelus $39.88 2024
Kowa Pharmaceuticals America, INC. $39.27 2022-2023 Seglentis
Cerapedics INC. $38.98 2025 I-Factor Peptide Enhanced Bone Graft
Azurity Pharmaceuticals, INC. $31.36 2023 Horizant
Smith+Nephew, INC. $28.28 2020
Pacira Therapeutics, INC. $23.73 2019
Ctl Medical Corporation $23.47 2021
Spinal Simplicity, LLC $22.83 2022
Zimmer Biomet Holdings, INC. $22.46 2019
Bioventus LLC $17.80 2024 Durolane
Ermi LLC $17.46 2021
Tactile Systems Technology INC $15.88 2021
Abbvie INC. $14.57 2022
Theragen, INC. $13.01 2023 Actastim-S
Pfizer INC. $11.60 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher E Cenac

$33,068.99

in general payments reported 2019-2025

Years
2019-2025
Top company
Centinel Spine, LLC
Context
The $8,044 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).

https://glasscript.com/doctor/334353/christopher-e-cenac

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.